| Literature DB >> 35831762 |
Hui Wang1, Guo-Qing Sui2, Zhi-Xia Sun3, Jia-Rui Du4, Yang Wang4, Zong-Hua Yue4, Han-Yu Zhang4.
Abstract
Tumor immunotherapy has become an important means of tumor therapy by enhancing the immune response and triggering the activation of immune cells. However, currently, only a small number of patients respond to immunotherapy alone, and patients may experience immune-related adverse events (irAEs) during the course of treatment. Sonodynamic therapy (SDT) can produce cytotoxic substances to tumor tissue, induce apoptosis and enhance immunity. SDT combined with immunotherapy is considered a promising strategy for cancer treatment. In this mini review, we summarize the role of SDT in immunotherapy in recent years, including the application of SDT-triggered immunotherapy and the combination of SDT and immunotherapy.Entities:
Keywords: Immune; Immunotherapy; Sonodynamic therapy; Ultrasound
Year: 2022 PMID: 35831762 DOI: 10.1007/s00432-022-04190-z
Source DB: PubMed Journal: J Cancer Res Clin Oncol ISSN: 0171-5216 Impact factor: 4.322